Charles Schwab Investment Management Inc Ardelyx, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Ardelyx, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,938,778 shares of ARDX stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,938,778

Previous 1,898,076 2.14%

Holding current value

$10.1 Million

Previous $14.1 Million 5.02%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.28 - $7.57 $214,906 - $308,114	40,702 Added 2.14%	1,938,778 $13.4 Million
Q2 2024 Aug 12, 2024	BUY	$5.89 - $9.31 $260,626 - $411,958	44,249 Added 2.39%	1,898,076 $14.1 Million
Q1 2024 May 08, 2024	BUY	$6.05 - $9.74 $224,424 - $361,305	37,095 Added 2.04%	1,853,827 $13.5 Million
Q4 2023 Feb 06, 2024	BUY	$3.29 - $6.64 $495,029 - $999,087	150,465 Added 9.03%	1,816,732 $11.3 Million
Q3 2023 Nov 08, 2023	BUY	$3.3 - $4.83 $3.57 Million - $5.23 Million	1,082,554 Added 185.46%	1,666,267 $6.8 Million
Q2 2023 Aug 09, 2023	BUY	$3.23 - $4.95 $1.62 Million - $2.48 Million	501,745 Added 612.12%	583,713 $1.98 Million
Q4 2022 Feb 13, 2023	BUY	$1.22 - $2.85 $39,000 - $91,108	31,968 Added 63.94%	81,968 $233,000
Q2 2022 Aug 15, 2022	SELL	$0.51 - $1.17 $106,805 - $245,023	-209,422 Reduced 80.73%	50,000 $30,000
Q4 2021 Feb 11, 2022	BUY	$0.86 - $1.7 $65,497 - $129,472	76,160 Added 41.56%	259,422 $286,000
Q3 2021 Nov 16, 2021	SELL	$1.27 - $8.17 $32,702 - $210,377	-25,750 Reduced 12.32%	183,262 $242,000
Q2 2021 Aug 16, 2021	SELL	$6.55 - $8.98 $214,086 - $293,511	-32,685 Reduced 13.52%	209,012 $1.59 Million
Q1 2021 May 17, 2021	BUY	$6.1 - $7.69 $25,491 - $32,136	4,179 Added 1.76%	241,697 $1.6 Million
Q4 2020 Feb 16, 2021	BUY	$5.05 - $7.1 $20,376 - $28,648	4,035 Added 1.73%	237,518 $1.54 Million
Q3 2020 Nov 13, 2020	SELL	$5.25 - $7.08 $36,041 - $48,604	-6,865 Reduced 2.86%	233,483 $1.23 Million
Q2 2020 Aug 14, 2020	BUY	$5.37 - $8.11 $456,782 - $689,852	85,062 Added 54.78%	240,348 $1.66 Million
Q1 2020 May 15, 2020	BUY	$4.35 - $8.79 $138,330 - $279,522	31,800 Added 25.75%	155,286 $883,000
Q4 2019 Feb 07, 2020	BUY	$4.23 - $8.29 $45,244 - $88,669	10,696 Added 9.48%	123,486 $927,000
Q2 2019 Aug 09, 2019	SELL	$2.49 - $3.73 $117,899 - $176,611	-47,349 Reduced 29.57%	112,790 $304,000
Q1 2019 May 14, 2019	SELL	$1.88 - $3.35 $164,913 - $293,862	-87,720 Reduced 35.39%	160,139 $449,000
Q3 2018 Nov 13, 2018	BUY	$3.75 - $4.65 $190,222 - $235,875	50,726 Added 25.73%	247,859 $1.08 Million
Q2 2018 Aug 08, 2018	BUY	$3.7 - $5.8 $491,334 - $770,199	132,793 Added 206.39%	197,133 $730,000
Q3 2017 Nov 13, 2017	BUY	$4.35 - $5.7 $279,879 - $366,738	64,340	64,340 $361,000

Others Institutions Holding ARDX

# of Institutions

219

Shares Held

141M

Call Options Held

1.08M

Put Options Held

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $804M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Ardelyx, Inc. Transaction History